Pathogenic fungi, particularly Candida auris, are responsible for millions of annual deaths and pose significant global health challenges, especially in vulnerable populations. Current drug resistance and slow diagnosis contribute to the crisis, while only a few promising therapies exist. WHO's recent reports emphasize the urgent need for enhanced testing and treatment strategies. Collaboration among researchers, policymakers, and industry is crucial to develop affordable diagnostics and protect the efficacy of existing antifungals, ensuring timely interventions against these dangerous infections, particularly in low and middle-income regions.
Pathogenic fungi pose unique challenges, and overcoming them will require innovative approaches to both science and policy.
Despite the growing global threat posed by drug-resistant fungi, such infections rarely loom large in discussions of antimicrobial resistance.
Collection
[
|
...
]